BN Business News
Şirketinizi ekleyin →
Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.

İş dünyası · 22.06.20201 dk okuma

Hospira, Inc., et al.; Withdrawal of Approval of 12 Abbreviated New Drug Applications; Correction

Yerel otomatik çeviri · Kaynağın orijinal dili

Özet

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of February 12, 2019. The document announced the withdrawal of approval of 12 abbreviated new drug applications (ANDAs) from multiple applicants. The document erroneously included ANDA 077736 for Polyethylene Glycol 3350 Powder for Oral Solution, 17 grams/scoopful, held by Breckenridge Pharmaceutical, Inc. (Breckenridge). This document corrects that error.

Kaynağın orijinal dili: Federal Register — Food and Drug AdministrationOrijinal duyuruyu açın →